| Literature DB >> 35370411 |
Yanwu Nie1, Chenchen Wang2, Lei Yang3, Zhen Yang4, Yahong Sun4, Maozai Tian5,6, Yuhua Ma7,8, Yuxia Zhang9, Yimu Yuan10, Liping Zhang6.
Abstract
Purpose: The role of inorganic arsenic (iAs) in the risk of metabolic syndrome (MetS) remains unclear. This investigation focused on the effect of iAs exposure on MetS and whether the results are consistent in different subgroups. Patients andEntities:
Keywords: metabolic syndrome; propensity score matching; subgroup analysis; urinary inorganic arsenic
Year: 2022 PMID: 35370411 PMCID: PMC8965335 DOI: 10.2147/DMSO.S349583
Source DB: PubMed Journal: Diabetes Metab Syndr Obes ISSN: 1178-7007 Impact factor: 3.168
Baseline Characteristics Before and After Propensity Score Matching (PSM)
| Variables | Before Propensity Score-Matched | After Propensity Score-Matched | ||||
|---|---|---|---|---|---|---|
| Without MetS (n=950) | With MetS (n=295) | P value | Without MetS (n=248) | With MetS (n=248) | P value | |
| Urinary inorganic arsenic (μg/dL) | 0.22(0.19) | 0.25(0.18) | 0.001 | 0.22(0.19) | 0.25(0.16) | 0.009 |
| Sex | ||||||
| Woman | 462 (48.60) | 154 (52.20) | 0.287 | 118 (47.60) | 130 (52.40) | 0.323 |
| Man | 488 (51.40) | 141 (47.80) | 130 (52.40) | 118 (47.60) | ||
| Age (years) | 49.42±10.14 | 53.25±9.75 | 0.000 | 52.44±9.69 | 52.18±9.44 | 0.768 |
| BMI (kg/m2) | 24.47±3.65 | 27.89±3.64 | 0.000 | 27.41±3.51 | 27.25±3.31 | 0.606 |
| Hemoglobin (g/L) | 135.39±21.08 | 137.60±20.93 | 0.114 | 137.86±18.83 | 137.05±21.15 | 0.651 |
| White blood cell count (109/L) | 6.84±1.91 | 7.06±1.72 | 0.072 | 6.91±1.81 | 6.99±1.65 | 0.593 |
| Plateletcount (109/L) | 278.29±90.54 | 265.40±64.88 | 0.023 | 268.24±81.56 | 266.53±64.44 | 0.795 |
| Glutamic-pyruvic transaminase (U/L) | 24.99±17.02 | 29.37±19.28 | 0.000 | 28.32±24.23 | 28.82±18.48 | 0.793 |
| Aspartate amino-transferase (U/L) | 23.49±13.83 | 23.09±13.60 | 0.662 | 23.74±11.56 | 22.85±13.88 | 0.440 |
| Serum creatinine (μmol/L) | 69.63±18.72 | 70.10±24.52 | 0.728 | 71.71±19.19 | 69.72±20.19 | 0.261 |
| Blood urea (mmol/L) | 5.58±2.04 | 5.87±5.66 | 0.188 | 5.84±1.98 | 5.84±5.60 | 0.997 |
| Total cholesterol (mmol/L) | 4.19±1.38 | 4.65±1.41 | 0.000 | 4.49±2.18 | 4.53±1.06 | 0.823 |
| LDL cholesterol (mmol/L) | 2.62±0.84 | 2.95±1.08 | 0.000 | 2.90±0.92 | 2.89±1.05 | 0.972 |
| Education level | ||||||
| Illiteracy | 59 (6.2) | 28 (9.5) | 0.072 | 13 (5.2) | 22 (8.9) | 0.130 |
| Primary Education | 493 (51.9) | 163 (24.8) | 155 (62.5) | 131 (52.8) | ||
| Junior middle Education | 344 (36.2) | 93 (21.3) | 70 (28.2) | 84 (33.9) | ||
| Senior middle Ed- ucation and above | 54 (5.7) | 11 (16.9) | 10 (4.0) | 11 (4.4) | ||
| Family history of hyperlipidemia | ||||||
| No | 893 (94.0) | 276 (93.6) | 0.781 | 232 (93.5) | 230 (92.7) | 0.859 |
| Yes | 57 (6.0) | 19 (6.4) | 16 (6.5) | 18 (7.3) | ||
| Eating habits | ||||||
| Meat-based | 156 (16.4) | 56 (19.0) | 0.352 | 52 (21.0) | 45 (18.1) | 0.103 |
| Vegetarian-based | 81 (8.5) | 30 (10.2) | 15 (6.0) | 28 (11.3) | ||
| Meat and vegetable | 713 (75.1) | 209 (70.8) | 181 (73.0) | 175 (70.6) | ||
| Smoking | ||||||
| No | 800 (84.2) | 256 (86.8) | 0.308 | 210 (84.7) | 214 (86.3) | 0.702 |
| Yes | 150 (15.8) | 39 (13.2) | 38 (15.3) | 34 (13.7) | ||
| Drinking | ||||||
| No | 872 (91.8) | 272 (92.2) | 0.903 | 227 (91.5) | 229 (92.3) | 0.869 |
| Yes | 78 (8.2) | 23 (7.8) | 21 (8.5) | 19 (7.7) | ||
Figure 1Distribution of propensity score before and after propensity score matching (PSM). (A) Propensity score distribution before PSM, (B) propensity score distribution after PSM. PSM matches by calculating the propensity score. When the propensity scores are consistent, it is considered that the matching efficiency is better.
Figure 2Standardized bias of variables before and after propensity score matching (PSM). ● Denotes the standardized bias of variables before PSM; x Denotes the standardized bias of variables after PSM; the two vertical dashed lines represent ±10% of the standardized bias respectively.
Figure 3Prevalence of metabolic syndrome components before PSM.
Logistic Regression Between Urinary Inorganic Arsenic (iAs) Content and MetS Before and After PSM
| Urinary iAs Content | Model 1a | Model 2b | Model 3c | |||
|---|---|---|---|---|---|---|
| OR (95% CI) | P1 | OR (95% CI) | P2 | OR (95% CI) | P3 | |
| Categoricald | ||||||
| < P25(Ref) | Ref | Ref | Ref | |||
| P25-(low) | 1.146 (0.729, 1.799) | 0.555 | 1.171 (0.736, 1.863) | 0.504 | 1.465 (0.873, 2.460) | 0.148 |
| P50-(medium) | 1.591 (1.036, 2.443) | 0.034 | 1.568 (1.008, 2.440) | 0.046 | 1.558 (0.930, 2.612) | 0.092 |
| P75-(high) | 2.113 (1.392, 3.208) | <0.001 | 2.011 (1.296, 3.120) | 0.002 | 2.003 (1.190, 3.371) | 0.009 |
| P for trend | <0.001 | 0.001 | 0.011 | |||
| Continuouse | ||||||
| 1.055 (1.024, 1.088) | <0.001 | 1.049 (1.016, 1.083) | 0.003 | 1.091 (1.025, 1.161) | 0.007 | |
Notes: aBefore PSM, adjusted the most common risk factors age and BMI in general demographic characteristics. bBefore PSM, Model 1 adjustments plus white blood cell count, platelet count, glutamic-pyruvic transaminase, total cholesterol, LDL cholesterol, education level (adjusted the variables with P value less than 0.1 in Table 1 before PSM). cAfter PSM, no variables were adjusted. d.According to the quartile of urinary iAs content in the control group, the urinary iAs content were divided into reference group, low, medium and high dose groups:P25=1.3 μg/dL; P50=2.2 μg/dL; P75=3.2 μg/dL. eUrinary iAs content was included in the logistic model as a continuous variable.
Figure 4Relationship between urinary iAs and MetS in different subgroups. OR (95% CI) greater than 1 indicates that iAs plays a predictive role in MetS. OR (95% CI) less than 1 indicates that iAs has a protective effect on MetS. * Denotes significance at a P value of <0.05.